July 5, 2023

dsm-firmenich completes acquisition of postbiotics pioneer Adare Biome

dsm-firmenich has confirmed the completion of its acquisition of Adare Biome, a pioneer in the development and manufacturing of postbiotics, for an enterprise value of €275 million (US$299.1 million).

The transaction represents an estimated 2023 EV/EBITDA multiple of 18x.

Adare Biome develops, produces and commercialises high-quality postbiotic solutions, including its pharmaceutical product, Lactéol, which is marketed in almost 40 countries around the world.

The company's ingredients, including LBiome™ and LBiotix™, are used for digestive health applications in humans and pets as well as in production animals like swine, ruminant, poultry and fish.

Adare Biome is based in Houdan, France.

- dsm-firmenich